Arachidonic acid release from PC12 pheochromocytoma cells is regulated by I1-imidazoline receptors.
Rat PC 12 pheochromocytoma cells lack alpha2-adrenergic receptors but express plasma membrane I1-imidazoline receptors. In response to the I1-agonist moxonidine, diglycerides are generated via phosphatidylcholine-selective phospholipase C, and prostaglandin E2 is released. This report characterizes I-receptor-mediated release of arachidonic acid, the precursor to the prostaglandins. PC12 cells were incubated with [3H]arachidonic acid for 24 h and superfused with 0.01% bovine serum albumin in Krebs' physiological buffer at 1 ml/min. Calcium ionophore increased arachidonic acid release only marginally, implying that in PC12 cells arachidonic acid release is not driven by calcium. The I1-agonist moxonidine at concentrations between 10 nM and 1.0 microM rapidly elicited up to two-fold increases in [3H]arachidonic acid release. Guanabenz, a potent alpha2-agonist and I2-ligand, had no effect. The selective I1-antagonist efaroxan blocked the action of moxonidine. The phospholipase A2 inhibitor aristolochic acid had no effect, suggesting that arachidonic acid release may be through an indirect pathway, possibly involving diglycerides. Thus, I1-imidazoline receptors in PC12 cells are coupled to arachidonic acid release through an as yet unknown pathway.
Ernsberger
P
P
Department of Nutrition, Case Western Reserve University School of Medicine Cleveland, OH 44106-4906, USA. pre@po.cwru.edu
D000316:Adrenergic alpha-Agonists / Q000494:pharmacology; D000317:Adrenergic alpha-Antagonists / Q000494:pharmacology; D000818:Animals; D016718:Arachidonic Acid / Q000378:metabolism*; D034341:Aristolochic Acids; D001572:Benzofurans / Q000494:pharmacology; D004791:Enzyme Inhibitors / Q000494:pharmacology; D006143:Guanabenz / Q000494:pharmacology; D007093:Imidazoles / Q000378:metabolism* / Q000494:pharmacology; D054755:Imidazoline Receptors; D016716:PC12 Cells; D010616:Phenanthrenes / Q000494:pharmacology; D010741:Phospholipases A / Q000037:antagonists & inhibitors; D054467:Phospholipases A2; D051381:Rats; D011955:Receptors, Drug / Q000819:agonists / Q000037:antagonists & inhibitors / Q000378:metabolism*
D000316:Adrenergic alpha-Agonists; D000317:Adrenergic alpha-Antagonists; D034341:Aristolochic Acids; D001572:Benzofurans; D004791:Enzyme Inhibitors; D007093:Imidazoles; D054755:Imidazoline Receptors; D010616:Phenanthrenes; D011955:Receptors, Drug; D016718:Arachidonic Acid; C000228:aristolochic acid I; C043482:moxonidine; D010741:Phospholipases A; D054467:Phospholipases A2; C062597:efaroxan; D006143:Guanabenz